What if I am looking for help with weight?
A Providence search takes you to weight-care offers. Some name familiar medicines; others focus on a blend or a newer ingredient.
A familiar ingredient makes every version equivalent
GLP-1 is a natural hormone linked to appetite and blood sugar; medicines that imitate it are also described by that name.
The exact product and purpose come first
For type 2 diabetes or long-term weight care, approved medicines are available as of September 26, 2026. The approval comes from FDA, the Food and Drug Administration. For semaglutide, examples include the brands Ozempic and Wegovy; for tirzepatide, they include Mounjaro and Zepbound.
The use depends on the exact product. Ask what condition the proposed medicine would treat. Ask the clinician to show you that use in the official prescribing information, the detailed medicine document linked below.
Check the date behind a shortage explanation
As of September 26, 2026, FDA’s drug shortage list does not include semaglutide injections or tirzepatide.
An individual patient’s medicine can be prepared to order through compounding.
As of September 26, 2026, pharmacies can no longer rely on a national shortage to justify making copies of these medicines. A medicine prepared to order for one patient may still be allowed if the other compounding rules are met.
Ask which adjustment your care calls for and the rule that permits it. An old shortage does not answer those questions.
A pharmacy being temporarily out of stock is a different question from a national shortage listing. Ask which explanation applies to the offer you are seeing.
Newer names do not mean cleared medicines
FDA identifies a federal ban on using retatrutide or cagrilintide to compound medicines, as of September 26, 2026.
Neither medicine, as of September 26, 2026, has been found safe and effective by FDA for any condition.
Do not use a treatment menu as proof of approval. Ask the clinician to identify the approved product, if that is what the service claims to offer.
Ask about the plan beyond a prescription
Discuss the reason for treatment, other options, follow-up and the cost if insurance declines payment. Bring questions about your other medicines and any plans for pregnancy to the clinician.
Leave knowing how to send questions once the visit is over. A product name alone does not explain what ongoing care will involve.